Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hesterkamp

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Topics in Microbiology and Immunology|July 12, 2015
Antibiotics Clinical Development and PipelineThomas Hesterkamp
Current Opinion in Chemical Biology|March 5, 2008
Fragment-based activity space: smaller is betterThomas Hesterkamp, Mark Whittaker
Journal of Biomolecular Screening|March 31, 2012
On the prediction of statistical parameters in high-throughput screening using resampling techniquesPierre E Ilouga, Thomas Hesterkamp
Current Opinion in Drug Discovery & Development|April 28, 2009
A multiplexed approach to hit findingMark Slack, Dirk Winkler, Joachim Krämer, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Fragment screening by biochemical assayJohn Barker, Steve Courtney, Thomas Hesterkamp, et al.
Protein Science : a Publication of the Protein Society|November 26, 2009
High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligandRobert Cheng, Brunella Felicetti, Shilpa Palan, et al.
Journal of Computer-Aided Molecular Design|June 18, 2009
The multiple roles of computational chemistry in fragment-based drug designRichard Law, Oliver Barker, John J Barker, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug TransportersKatharina Rox, Annett Kühne, Jennifer Herrmann, et al.
EMBO Reports|December 19, 2022
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterialsSebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Fragment-based discovery and optimization of BACE1 inhibitorsJames Madden, Jenny R Dod, Robert Godemann, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Topics in Microbiology and Immunology|July 12, 2015
Antibiotics Clinical Development and PipelineThomas Hesterkamp
Current Opinion in Chemical Biology|March 5, 2008
Fragment-based activity space: smaller is betterThomas Hesterkamp, Mark Whittaker
Journal of Biomolecular Screening|March 31, 2012
On the prediction of statistical parameters in high-throughput screening using resampling techniquesPierre E Ilouga, Thomas Hesterkamp
Current Opinion in Drug Discovery & Development|April 28, 2009
A multiplexed approach to hit findingMark Slack, Dirk Winkler, Joachim Krämer, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Fragment screening by biochemical assayJohn Barker, Steve Courtney, Thomas Hesterkamp, et al.
Protein Science : a Publication of the Protein Society|November 26, 2009
High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligandRobert Cheng, Brunella Felicetti, Shilpa Palan, et al.
Journal of Computer-Aided Molecular Design|June 18, 2009
The multiple roles of computational chemistry in fragment-based drug designRichard Law, Oliver Barker, John J Barker, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug TransportersKatharina Rox, Annett Kühne, Jennifer Herrmann, et al.
EMBO Reports|December 19, 2022
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterialsSebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Fragment-based discovery and optimization of BACE1 inhibitorsJames Madden, Jenny R Dod, Robert Godemann, et al.
Pageof 3